Sanofi India share news, announcements and annual reports
NSE: SANOFIBSE: 500674Pharmaceuticals & BiotechnologySmall Cap
Sanofi India Limited · Formerly Aventis Pharma · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1984 on BSE, May 2003 on NSE
Last close ₹3,204.10up ₹14.60 (0.46%)BSE ₹3,204.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,189.50.
30 Oct: open ₹3,265.00, high ₹3,422.60, low ₹3,175.10
52-week range of traded prices to 30 Oct 2026
₹2,758.20Low, 23 Oct 2026₹4,834.00High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,379 Cr614th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.84%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 45.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 57.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Jun 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,04,44220.0% delivered
Sanofi India share news and announcements
701 announcements, routine notices left out, newest first. Page 14 of 15.
Apr 2009
15 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2009 (which is the first quarter of the Company's financial year).
Mar 2009
2 Mar · Meeting
Register of Members and Share Transfer Books of the Company will be closed from April 09, 2009 to April 28, 2009 (both days inclusive) for the following purposes: [1] Annual General Meeting to be held on April 28, 2009. [2] Payment of Final Dividend for the year ended December 31, 2008, if declared at the Annual General Meeting to be held on April 28, 2009.
Feb 2009
18 Feb · Disclosure
Disclosure pursuant to Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) (Amendment) Regulations, 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Feb · Dividend
Board of Director at its meeting held on February 17, 2009 recommended a Final dividend of Rs.12.50 per Equity share of Rs.10 for the year ended December 31, 2008. An Interim dividend of Rs.3.50 per Equity share of Rs.10 had been paid in August 2008.17 Feb · Results
Standalone Results for the year ended on 31-DEC-2008 as follows: Net Sales of Rs. 98330 lacs for year ending on 31-DEC-2008 against Rs. 87350 lacs for the year ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 16620 lacs for the year ending on 31-DEC-2008 against Rs. 14440 lacs for the year ending on 31-DEC-2007.17 Feb · Results
Standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 26990 lacs for quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 4530 lacs for the quarter ending on 31-DEC-2008.6 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2008 and also to consider recommendation of Final Dividend for the said financial year.5 Feb · Updates
We had stated in the notes to the Unaudited Financial Results of our Company for the quarter ended 30th June 2008, that all disputes between the Company, Chiron Behring Vaccines Private Limited (CBVPL) (in which the Company holds 49%) and Novartis Vaccines & Diagnostics Inc. (the Company's Joint Venture Partner in CBVPL) regarding the Notice of non- renewal of the distribution agreement for Rabipur Vaccine between the Company and CBVPL for India and Nepal, had been referred to the Sole Arbitrator, Mr. Justice S. P. Bharucha, former Chief Justice of India. We have now to inform you that the Arbitrator has passed an award on 4th February 2009 holding that the said distribution agreement was not renewed with effect from 1st May 2008. However, CBVPL and Novartis Vaccines & Diagnostics Inc. had agreed that the distribution agreement would operate until the award was made and for 2 weeks thereafter. Sales of Rabipur for the nine months ended 30th September 2008 were Rs.88 crores. The Company will continue to hold 49% shareholding in CBVPL and derive the benefits therefrom
Jan 2009
12 Jan · Results
Company will not publish the Unaudited Financial Results for the quarter ended December 31, 2008 and the company undertakes to publish the Audited Results for the year ended December 31, 2008 before March 31, 2009.
Oct 2008
23 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 24790 lacs for quarter ending on 30-SEP-2008 against Rs. 22640 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 4460 lacs for the quarter ending on 30-SEP-2008 against Rs. 3680 lacs for the quarter ending on 30-SEP-2007.7 Oct · Board meeting
For approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2008.
Jul 2008
24 Jul · Dividend
Board of Directors of the Company at its meeting held on July 24, 2008 has declared an interim dividend of Rs. 3.50 per Equity Share of Rs 10/-.24 Jul · Results
Standalone Results for the half year ended on 30-JUN-2008 as follows: Net Sales of Rs. 46550 lacs for half year ending on 30-JUN-2008 against Rs. 44310 lacs for the half year ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 7630 lacs for the half year ending on 30-JUN-2008 against Rs. 8060 lacs for the half year ending on 30-JUN-2007.24 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 24860 lacs for quarter ending on 30-JUN-2008 against Rs. 23020 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 4180 lacs for the quarter ending on 30-JUN-2008 against Rs. 3730 lacs for the quarter ending on 30-JUN-2007.14 Jul · Board meeting
For approval of the Unaudited Financial Results for the quarter and half year ended June 30, 2008, the Board of Directors will also consider the question of declaring an Interim dividend for the current financial year ending on December 31, 2008. In case Interim Dividend is declared by the Board at the said Meeting, the Record Date for the purpose of payment of such Interim Dividend will be July 30, 2008.
May 2008
26 May · Meeting
Minutes of the Annual General Meeting of the members of the company held on April 24, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 May · Business
Press release dated April 29, 2008, titled "Sanofi-aventis launches SoloSTAR(R)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
26 Apr · Updates
Copy of the Speech of the Chairman, Dr. Vijay Mallya delivered at the Annual General Meeting held on April 24, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Apr · Dividend
Board of Directors had, at its meeting held on February 21, 2008, recommended a Final dividend of Rs.12.50 per Equity share of Rs.10 for the year ended December 31, 2007. The dividend, if declared at the Annual General Meeting to be held on April 24, 2008, will be paid on or after April 25, 2008.23 Apr · Results
Standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 21690 lacs for quarter ending on 31-MAR-2008 against Rs. 21290 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 3450 lacs for the quarter ending on 31-MAR-2008 against Rs. 4330 lacs for the quarter ending on 31-MAR-2007.11 Apr · Board meeting
Meeting on 23 Apr 2008: “Unaudited Financial Results for the qtr ended March 31, 2008”
Mar 2008
5 Mar · Meeting
Register of Members and Share Transfer Books of the Company will be closed from April 05, 2008 to April 24, 2008 (both days inclusive) for the following purposes:- 1) Annual General Meeting to be held on April 24, 2008. 2) Payment of Final Dividend for the year ended December 31, 2007, if declared at the Annual General Meeting to be held on April 24, 2008.
Feb 2008
21 Feb · Dividend
Board of Directors in its meeting held on February 21, 2008 has recommended a Final Dividend of Rs.12.50 per Equity share of Rs.10 for the year ended December 31, 2007. An Interim dividend of Rs.3.50 per Equity share of Rs.10 had been paid in August 2007.21 Feb · Results
Standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 20400 lacs for quarter ending on 31-DEC-2007 against Rs. 21760 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 2700 lacs for the quarter ending on 31-DEC-2007 against Rs. 3470 lacs for the quarter ending on 31-DEC-2006.21 Feb · Results
Standalone Results for the year ended on 31-DEC-2007 as follows: Net Sales of Rs. 87350 lacs for year ending on 31-DEC-2007 against Rs. 88400 lacs for the year ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 14440 lacs for the year ending on 31-DEC-2007 against Rs. 16930 lacs for the year ending on 31-DEC-2006.8 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2007 and also to consider recommendation of Final Dividend for the said financial year.
Jan 2008
3 Jan · Results
Company will not publish the Unaudited Financial Results for the quarter ended December 31, 2007 and undertakes to publish the Audited Results for the year ended December 31, 2007 before March 31, 2008.
Oct 2007
19 Oct · Board meeting
Meeting on 30 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Jul 2007
26 Jul · Business
Press release dated July 26, 2007, titled "Aventis Pharma Limited (SANOFI-AVENTIS GROUP) and Themis Laboratories Pvt. Ltd. Sign Technology Transfer Deal". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jul · Business
Press release dated July 18, 2007, titled "Aventis Pharma Limited- Sales and Profit for Q2 2007 and H1 2007". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jul · Dividend
Board of Directors of the Company has, at its meeting held on July 17, 2007, declared an Interim Dividend of Rs.3.50 per Equity Share of Rs.10 for the financial year ending December 31, 2007.17 Jul · Results
Standalone Results for the half year ended on 30-JUN-2007 as follows: Net Sales of Rs. 44310 lacs for half year ending on 30-JUN-2007 against Rs. 42330 lacs for the half year ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 8060 lacs for the half year ending on 30-JUN-2007 against Rs. 8080 lacs for the half year ending on 30-JUN-2006.17 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 23020 lacs for quarter ending on 30-JUN-2007 against Rs. 22280 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 3730 lacs for the quarter ending on 30-JUN-2007 against Rs. 4390 lacs for the quarter ending on 30-JUN-2006.17 Jul · Meeting
Minutes of the Annual General Meeting of the Members of the Company held on June 15, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Jul · Corporate action
In case Interim Dividend is declared by the Board at its Meeting to be held on July 17, 2007, the Record Date for the purpose of payment of such second Interim Dividend will be July 26, 2007.10 Jul · Board meeting
For :- (a) Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2007; and (b) Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2007.
Jun 2007
19 Jun · Miscellaneous
Speech of Chairman, Dr. Vijay Mallya delivered at the Annual General Meeting held on June 15, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Jun · Meeting
Notice of the Annual General Meeting of the Company to be held on June 15, 2007. A copy of the AGM notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2007
19 Apr · E-mail ID for Investor Complaints
The following e-mail id has been designated for the purpose of registering complaints by investor :- igrc.apl@sanofi-aventis.com This e-mail id is also being displayed on the Company's website (www.aventispharmaindia.com). This e-mail id would be in addition to the following existing e-mail id of the Compliance Officer :- K.Subramani@sanofi-aventis.com18 Apr · Management
The Board of Directors has, at its Meeting held on 16th April, 2007, appointed Mr. S.C. Ghoge as Alternate Director to Mr. Eric Le-Bris. Mr. Ghoge being an employee of the Company, has been appointed a Wholetime Director17 Apr · Business
Media release dated April 16, 2007, titled "Aventis Pharma Limited announces its Sales and Profit for Q1 2007". The details of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Apr · Board meeting
Meeting on 16 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”5 Apr · Meeting
The Register of Members and Share Transfer Books of the Company will be closed from 5th June 2007 to 15th June 2007 (both days inclusive) for the purpose of Annual General meeting which is being held on 15th June 2007.
Mar 2007
26 Mar · Board meeting
Board of Directors, at their meeting held on March 26, 2007, has not recommended any Final Dividend for the year ended December 31, 2006 in view of the earlier declarations by the Board of Directors of the (a) First Interim Dividend of Rs. 3.50 per equity share of Rs. 10 which was paid in August 2006 and (b) Second Interim Dividend of Rs. 28.50 per equity share of Rs. 10 (inclusive of a Special One-time Golden Jubilee Dividend of Rs. 16.00 per equity share of Rs. 10), which was declared on March 16, 2007 with the Record Date being March 24, 2007.26 Mar · Business
Media release dated March 26, 2007, titled "Aventis Pharma Limited announces its Sales and Profit for 2006". The details of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Mar · Management
Mr. F. Delille, Director has resigned as Director on 7th March, 2007. At its Meeting held on 16th March, 2007, the Board has appointed Mr. Eric Le-Bris as an Additional Director16 Mar · Board meeting
For approving the audited Accounts for the year ended December 31, 2006 and also to consider recommendation of Final Dividend for the said financial year.16 Mar · Dividend
March 16, 2007 that: "The Board of Directors of the Company has, at its Meeting held today, declared a Second Interim Dividend of Rs.28.50 per Equity Share of Rs.10 (which is inclusive of a Special One-time Golden Jubilee Dividend of Rs.16.00 per Equity Share to commemorate the completion of fifty years of the Company which was incorporated in May 1956) for the financial year ended 31st December 2006. The said Interim Dividend will be paid to those Members whose names appear on the Register of Members on 24th March 2007, being the Record Date fixed for this purpose".9 Mar · Board meeting
For considering the question of declaring a Second Interim Dividend for the financial year ended December 31, 2006. In case the said Interim Dividend is declared by the Board at its aforesaid Meeting, the Record Date for the purpose of payment of such second Interim Dividend will be March 24, 2007.6 Mar · Management
Dr. S. Bhattacharya, Wholetime Director and Alternate Director of the Company has resigned as Director and as an employee of the Company with effect from the close of business hours on 23rd February 2007 as he has taken up an overseas appointment outside the Company